Metabolomic Biomarkers of Myotonic Dystrophy | stella

Learn Find trials matched to me

Learn Find trials matched to me →

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Privacy For Researchers Data Labs ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Metabolomic Biomarkers of Myotonic Dystrophy | stella

Back to Myotonic Dystrophy Type 1 trials

Recruiting

Plain-English translation of NCT07912983 on ClinicalTrials.gov ↗ · Source last updated November 2026 · How we translate trials

Trial locations(1 site)

United States

Massachusetts General Hospital, Boston, Massachusetts

Key details

Sponsor

Massachusetts General Hospital

Enrollment target

~64 participants

Started

October 2026

Primary completion

August 2030

Age range

14 Years and older

Last updated on clinicaltrials.gov in November 2026.

Contact the research team directly

Reach out to the team running this trial. Response times vary — some teams are faster than others.

Central contact

Tamkin Shahraki, MD

Massachusetts General Hospital

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov